Morphic Holding, Inc. Rings the Closing Bell
ABOUT THIS EVENT
Morphic Holding, Inc. (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, Praveen Tipirneni, President & CEO, rang the Closing Bell.